// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PRIDE:0000831 HANCESTRO PTM DDA MC ENVO PS WARRANTY PROTEOMICS PRIDE IMPLIED OF CL SILAC CF CELL NOTE technical replicate MS:1001251 MERCHANTABILITY README URL IAA BE DJ reduction reagent INCLUDING PRIDE:0000833 BMC file your FDR EFO REQUIRED HF JA PO INFRINGE BRENDA CPTAC TO DTT PP EBI MHC FITNESS SH cleavage agent details PATCH SWATH COULD REQUIRES XML dissociation method CLO THAT alkylation reagent ALL HCD ancestry category MAGE NCIT:C25683 BTO OR PARTICULAR DISCLAIMS PRIDE:0000834 LC fractionation method PRIDE:0000659 QY label IMPORTANT PMCID NCIT NT AC VK ZFA MOD DIA NCBI IDF ANY depletion MT SHOULD ISA PATO SDRF NCE CV III WARRANTIES II NCI RIGHTS CN RECOMMENDED INITIATIVE cell type MONDO CID SP EM RECOMMEND HUPO SRM EXPRESS biosample accession number data file TAB LIMITED SN IS PRM ID PMID sample TMT SAMN MINOR SAMEA source name PEPTIDESEQ developmental stage COLUMN pooled sample THE CS STANDARDS AS ROW HEREIN biological replicate sex fraction identifier UBERON mass PURPOSE XL spiked compound exclamation MS proteomics data acquisition method characteristics SHALL NOT MAY PRIDE:0000832 OPTIONAL WILL HTML individual CT EW organism USE FOR RAW ... MIAME NCIT:C25714 VCF disease BUT MUST URI organism part age collision energy PSI TIP TA INFORMATION LI instrument RFC MAJOR"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PRIDE:0000831 HANCESTRO PTM DDA MC ENVO PS WARRANTY PROTEOMICS PRIDE IMPLIED OF CL SILAC CF CELL technical replicate MS:1001251 MERCHANTABILITY README URL IAA BE DJ reduction reagent INCLUDING PRIDE:0000833 BMC FDR EFO REQUIRED HF JA PO INFRINGE BRENDA CPTAC TO DTT PP EBI MHC FITNESS SH cleavage agent details PATCH SWATH COULD REQUIRES dissociation method CLO THAT alkylation reagent ALL HCD MAGE NCIT:C25683 BTO OR PARTICULAR DISCLAIMS PRIDE:0000834 LC fractionation method PRIDE:0000659 QY label PMCID NCIT NT AC VK ZFA MOD DIA NCBI IDF ANY depletion MT SHOULD ISA PATO SDRF NCE CV III WARRANTIES II NCI RIGHTS CN RECOMMENDED INITIATIVE cell type MONDO CID SP EM RECOMMEND HUPO SRM EXPRESS biosample accession number data file TAB LIMITED SN IS PRM PMID TMT SAMN MINOR SAMEA PEPTIDESEQ COLUMN pooled sample THE CS STANDARDS AS ROW HEREIN biological replicate fraction identifier UBERON mass PURPOSE XL spiked compound MS proteomics data acquisition method SHALL NOT MAY PRIDE:0000832 OPTIONAL WILL HTML individual CT EW organism USE FOR RAW ... MIAME NCIT:C25714 VCF disease BUT MUST URI organism part age collision energy PSI TA INFORMATION LI instrument RFC MAJOR"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "HANCESTRO PATO UBERON:0000178 PTM DOID SDRF APP cell type biological replicate sex PATO:0000384 xenograft UBERON MONDO exclamation CL CL:0000084 MAY UBERON:0002107 ancestry category PDX individual organism synthetic peptide ID CL:0000624 enrichment process disease EFO PATO:0000383 MUST organism part age PO NCBI MONDO:0004989 PATO:0000461 depletion CL:0000066 developmental stage CL:0000815"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "HANCESTRO PATO UBERON:0000178 PTM DOID SDRF APP cell type biological replicate sex PATO:0000384 xenograft UBERON MONDO CL CL:0000084 MAY UBERON:0002107 ancestry category PDX individual organism synthetic peptide ID CL:0000624 enrichment process disease EFO PATO:0000383 MUST organism part age PO NCBI MONDO:0004989 PATO:0000461 depletion CL:0000066 developmental stage CL:0000815"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28076 HIPAA HANCESTRO NCIT:C27966 MONDO:0005148 NCIT:C15262 NCIT:C4870 SDRF NCIT:C65108 sampling time point NCI disease stage Dukes stage weight TNM NCIT:C65107 smoking status MONDO exclamation GDPR treatment ER NCIT:C28078 compound ancestry category TNM staging NCIT:C18206 MONDO:0005044 individual PR HANCESTRO:0005 NCIT:C15632 HANCESTRO:0009 body mass index NCIT:C65106 NCIT:C53554 tumor grade treatment status NCIT:C71732 pre-existing condition ID IMPORTANT treatment response NCIT IV AJCC breast cancer subtype CHEBI:28748 organism part menopausal status CHEBI:27899 Ann Arbor stage dose NCIT:C27971"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C28076 HIPAA HANCESTRO NCIT:C27966 MONDO:0005148 NCIT:C15262 NCIT:C4870 SDRF NCIT:C65108 sampling time point NCI disease stage Dukes stage weight TNM NCIT:C65107 smoking status MONDO GDPR treatment ER NCIT:C28078 compound ancestry category TNM staging NCIT:C18206 MONDO:0005044 individual PR HANCESTRO:0005 NCIT:C15632 HANCESTRO:0009 body mass index NCIT:C65106 NCIT:C53554 tumor grade treatment status NCIT:C71732 pre-existing condition ID treatment response NCIT IV AJCC breast cancer subtype CHEBI:28748 organism part menopausal status CHEBI:27899 Ann Arbor stage dose NCIT:C27971"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 SDRF DDA UNIMOD:35 MGF cleavage agent details proteomexchange accession number MS1 scan range RECOMMENDED file uri PRIDE fraction identifier exclamation PP MS UNIMOD proteomics data acquisition method SILAC SRM data file technical replicate scan window lower limit MS:1001251 URL precursor mass tolerance modification parameters PRM label fraction RAW ID UNIMOD:4 NT REQUIRED HF MUST scan window upper limit TMT AC URI MS2 analyzer type DIA PSI MOD TA fragment mass tolerance MT SHOULD instrument PRIDE:0000663"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 SDRF DDA UNIMOD:35 MGF cleavage agent details proteomexchange accession number MS1 scan range RECOMMENDED file uri PRIDE fraction identifier PP MS UNIMOD proteomics data acquisition method SILAC SRM data file technical replicate scan window lower limit MS:1001251 URL precursor mass tolerance modification parameters PRM label RAW ID UNIMOD:4 NT REQUIRED HF MUST scan window upper limit TMT AC URI MS2 analyzer type DIA PSI MOD TA fragment mass tolerance MT SHOULD instrument PRIDE:0000663"
  }
];
